IPOs

Welsh scientist makes potential $539m fortune from biotech flotation in US

Value of Andrew Hopkins’ Exscientia firm reaches market value of $2.9bn in Nasdaq IPO A Welsh scientist who dreamed up his artificial intelligence biotech company while walking home from the laboratory is sitting on a potential $539m (£400m) paper fortune after its $2.9bn stock market float. The idea for Exscientia, an Oxford-based firm that uses …

Welsh scientist makes potential $539m fortune from biotech flotation in US Read More »

Sunak’s stamp duty holiday extension has merely inflamed the housing market

Throwing money at an already heated market looks nonsensical and could lose the Treasury £2bn Surprise, surprise. Presented, or so they thought, with an end-March deadline to save a few thousand pounds on stamp duty, buyers rushed to complete their house purchases. Mortgage lending in the month reached a new record. It requires no imagination …

Sunak’s stamp duty holiday extension has merely inflamed the housing market Read More »

Investors flock to life sciences as UK sector breaks funding record

Covid crisis spurs growing interest in drugmakers, diagnostics and medical equipment firms UK drugmakers, diagnostics, medical equipment and other life sciences companies have raised £10.6bn from private funding rounds and stock market flotations in the first three months of the year, more than half of last year’s record total, according to a report. Last year, …

Investors flock to life sciences as UK sector breaks funding record Read More »

Biotech and medical device companies raise $913M in a five-IPO week

The five life sciences IPOs this week continues the steady march companies are making to the public markets this year. This week’s activity follows a first quarter that Renaissance Capital calculates was the busiest for newly public companies since 2000. Healthcare IPOs continued to dominate the stock offerings.

A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay

Vaccitech, the Oxford-based firm behind the AstraZeneca vaccine, is a high-profile float that slipped away A glowing, Deliveroo-style tribute from Rishi Sunak will not be required for this flotation. Vaccitech, the Oxford-based firm that owns some of the key biotechnology behind the AstraZeneca Covid vaccine, is off to New York for a public listing. One …

A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay Read More »